AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitlip M 50mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Mensa Futura Life Sciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitlip M 50mg/500mg Tablet SR

Diabetic patients with type 2 mellitus can manage elevated blood glucose with Sitlip M 50mg/500mg SR tablets, a dual-action medication. This combination therapy mitigates severe diabetic complications like vision impairment and kidney dysfunction, potentially lowering cardiovascular event risk (heart attack or stroke). Sitlip M 50mg/500mg SR may be used independently or in conjunction with other anti-diabetic treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, blood glucose levels, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management; lifestyle choices are key to blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and throat irritation. Hypoglycemia (low blood sugar) is a potential side effect, particularly when used with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication isn't universally suitable. Prior to commencing treatment, individuals with pre-existing kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption should consult their physician. Pregnant or lactating women require medical consultation before use. Potential drug interactions exist; disclose all medications to your doctor to ensure treatment safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout the treatment period.

Primary Ingredients of Sitlip M 50mg/500mg Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Sitlip M 50mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sitlip M 50mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Sitlip M 50mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing the tablet. It should be taken with a meal.

Common Side effects of Sitlip M 50mg/500mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitlip M 50mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitlip M 50mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Sitlip M 50mg/500mg Tablet SR works:

Sitagliptin and metformin, combined as Sitlip M 50mg/500mg SR tablets, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitlip M 50mg/500mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sitlip M 50mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitlip M 50mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Sitlip M 50mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician. Sitlip M 50mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The extended-release Sitlip M 50mg/500mg tablet is likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitlip M 50mg/500mg Tablet SR :

Should you forget to take a Sitlip M 50mg/500mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Sitlip M 50mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitlip M 50mg/500mg Tablet SR

Sitlip M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitlip M 50mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological symptoms such as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitlip M 50mg/500mg SR tablets may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Sitlip M 50mg/500mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitlip M 50mg/500mg Tablet SR is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitlip M 50mg/500mg SR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). While rare, this risk is increased in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitlip M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitlip M 50mg/500mg SR tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitlip M 50mg/500mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol with Sitlip M 50mg/500mg SR tablets is unsafe due to an increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitlip M 50mg/500mg SR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitlip M 50mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitlip M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitlip M 50mg/500mg SR tablets may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitlip M 50mg/500mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitlip M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitlip M 50mg/500mg SR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitlip M 50mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary or cognitive issues. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitlip M 50mg/500mg Table...
373